Cancer

Mass General Brigham investigators have developed a robust new artificial intelligence (AI) foundation model that is capable of analyzing brain MRI datasets to perform numerous medical tasks, including identifying brain age, predicting dementia risk, detecting […]

Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician, finds a study from China published by The BMJ. The researchers say using […]

Breast cancer (BC) is the most common cancer and the second leading cause of cancer death in women. It is a highly variable disease, defined as a malignancy of the epithelial ducts in breast tissue. […]

How to reduce suffering in children with advanced cancer remains an ongoing but urgent question. A Mass General Brigham-led study has examined whether systematically surveying children with advanced cancer and their parents about their symptoms […]

A study of U.S. veterans led by investigators at Mass General Brigham has identified a possible link between exposure to the Agent Orange herbicide and a rare melanoma subtype less likely to be related to […]

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment for the deadliest brain cancer. Researcher Hui Li, […]

A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute for Biological Studies, and UC San Diego has uncovered new genetic rules that determine how powerful immune cells—known as CD8+ […]

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have released updated consensus guidelines and an associated reproducibility study to standardize how pathologists assess tumor response to neoadjuvant therapy […]

A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors. The study focused on engineered invariant natural killer T cells, […]

A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body’s immune response to the tumor. This has been published in the journal Nature by a team led by researchers […]